Isotretinoin and inflammatory bowel disease.
Kendra Gail
KG
Bergstrom
D016022:Case-Control Studies; D003879:Dermatologic Agents / Q000009:adverse effects*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000139:chemically induced*; D015474:Isotretinoin / Q000009:adverse effects*
D003879:Dermatologic Agents; D015474:Isotretinoin